Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9607892 | 0.83 | ELANE (0.40) | KMT2AATMELANEALDH1A1KDM4E | |
| SCHEMBL15385625 | 0.82 | ELANE (0.44) | KMT2AATMELANEALDH1A1KDM4E | |
| SCHEMBL783650 | 0.82 | ESR1 (0.35) | KMT2AATMELANEKDM4E | |
| SCHEMBL17625770 | 0.77 | TNFSF11 (0.38) | KMT2AATMELANEALDH1A1KDM4E | |
| SCHEMBL22352931 | 0.77 | ELANE (0.36) | KMT2AATMELANEALDH1A1 | |
| SCHEMBL12196857 | 0.77 | ELANE (0.36) | KMT2AATMELANEALDH1A1KDM4E | |
| SCHEMBL15339235 | 0.77 | KMT2A (0.40) | KMT2AATMELANEALDH1A1KDM4E | |
| SCHEMBL19497323 | 0.76 | ELANE (0.36) | KMT2AATMELANEALDH1A1 | |
| SCHEMBL12636057 | 0.76 | ELANE (0.40) | KMT2AATMELANEALDH1A1 | |
| SCHEMBL18869157 | 0.75 | ELANE (0.35) | KMT2AATMELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9096795-B2 | Liquid crystal display | MERCK PATENT GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| US-9096795-B2 | Liquid crystal display | MERCK PATENT GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| US-20120069289-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-03-22 | — | — | US | disclosed |
| US-20120069289-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120069289-A1 | LIQUID CRYSTAL DISPLAY | LPXN, VCL, ACP3 | KMT2A 3141/4885ATM 2466/4885ELANE 761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.